Factors Leading to Urolithiasis in Patients with Metabolic Syndrome
Keywords:
metabolic syndrome, urolithiasis, abdominal obesity, arterial hypertension, hyperglycemia, diabetes mellitus type 2, hyperinsulinemia, insulin resistance.Abstract
This article analyzes the problem of urolithiasis disease (UD) which is one of most relevant in cotemporary urology and medicine in general. This is sacred first of all, with high prevalence of this diseases. According to several population studies, dissemination the strangeness of urolithiasis in world ranges from 3.5 to 9.6% [1]. At this, the proportion of urolithiasis among all urological diseases reaches 40% [2]. Relevance of this problem is also due to the fact that in 65–70% cases the disease is diagnosed in persons aged 20–60 years, that is, in the most active working age period of life. In addition, in 35 – 38% cases, the disease is recurrent general character, therefore of special significance from a medical and economic point of view long-term vision gains terms of rehabilitation and loss of employment abilities of these patients.
References
Curhan G, Goldfarb D, A. T. "Epidemiology of Stone Disease". 2nd International Consultation on Stone Disease // 2007. No. 9. R. 11-20.
Apolikhin O.I., Sivkov A.V., Beshliev D.A., Solntseva T.V., Komarova V.A. Analysis of uronephrological morbidity in the Russian Federation according to according to official statistics // Experimental and clinical research logy. 2010. No. 1. pp. 4 - 11.
Dzeranov N.K., Lopatkin N.A. Urolithiasis disease. Clinical recommendations. // M.: Ovreley, 2007. P.296.
Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. // Kidney Int. 2003. No. 5. R. 1817-23.
Lopatkin N.A., Dzeranov N.K. Fifteen years of experience in using DLT in the treatment of urolithiasis // Materials of the Plenum of the Board of the Russian Urology Society M. 2003. S. 5 – 25.
Borisov V.V., Dzeranov N.K. Conservative lithokinetic therapy kidney and ureteral stones. // M.: Ovreley, 2006. P. 56.
Tatevosyan A.S. Etiological and pathogenetic basis of nephrolithiasis. // Krasnodar: Soviet Kuban, 1997. 150 p.
West B, Luke A, Durazo-Arvizu RA, Cao G, Shoham D, Kramer H. Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988-1994. // Am J Kidney Dis. 2008. No. 5. R. 741-7.
Alberti KG, Zimmet P, Shaw J Metabolic syndrome—a new world-wide definition. A Consensus Statement from the International Diabetes Federation. // Diabet Med. 2006. No. 5. R. 469-80.
